Leap Therapeutics Inc (LPTX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Doug E. Onsi
Employees:
40
47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA 02142
617 252 4343

Leap Therapeutics, Inc. acquires and develops therapies for the treatment of cancer. DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers.

Data derived from most recent annual or quarterly report
Market Cap 56.613 Million Shares Outstanding88.32 Million Avg 30-day Volume 1.193 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.24
Price to Revenue265.7344 Debt to Equity0.0 EBITDA-53.254 Million
Price to Book Value1.4221 Operating Margin-14215.466699999999 Enterprise Value21.342 Million
Current Ratio6.819 EPS Growth-0.84 Quick Ratio6.68
1 Yr BETA 1.6669 52-week High/Low 2.57 / 0.4 Profit Margin-14208.5333
Operating Cash Flow Growth-53.6232 Altman Z-Score-1.4106 Free Cash Flow to Firm -37.033 Million
Earnings Report2023-03-10
View SEC Filings from LPTX instead.

View recent insider trading info

Funds Holding LPTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LPTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-01-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-17:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-07:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-09-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RICHARD CHRISTIAN M

    • Director
    0 2023-01-17 1

    MARTIN PATRICIA A.

    • Director
    0 2023-01-17 1

    SCHILSKY RICHARD

    • Director
    100,000 2022-09-06 2

    CAVANAUGH JAMES H

    • Director
    25,000 2022-09-01 2

    MIRABELLI CHRISTOPHER

    • Director
    200,000 2022-09-01 2

    LAWLOR AUGUSTINE CHIEF OPERATING OFFICER

    • Officer
    200,000 2022-09-01 2

    ONSI DOUGLAS E CEO,CFO,PRES.,GC,TREAS.,&SEC.

    • Officer
    • Director
    200,000 2022-09-01 2

    LI WILLIAM

    • Director
    25,000 2022-09-01 2

    LOSCALZO JOSEPH

    • Director
    25,000 2022-09-01 2

    MASHIACH NISSIM

    • Director
    25,000 2022-09-01 2

    DIETZ THOMAS JOHN

    • Director
    30,000 2022-09-01 2

    SIRARD CYNTHIA CHIEF MEDICAL OFFICER

    • Officer
    200,000 2022-09-01 2

    O'MAHONY JOHN MARK CHIEF MANUFACTURING OFFICER

    • Officer
    200,000 2022-09-01 2

    GRANFIELD CHRISTINE VP, HEAD OF REG AFFAIRS/QUAL

    • Officer
    200,000 2022-09-01 2

    BERTAGNOLLI MONICA

    • Director
    55,000 2022-01-31 1

    PERCEPTIVE ADVISORS LLC

    PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

    EDELMAN JOSEPH

    • 10% Owner
    11,985,267 2021-09-24 0

    BEIGENE, LTD.

    • 10% Owner
    7,348,437 2021-09-24 0

    HEALTHCARE VENTURES IX, L.P.

    HEALTHCARE PARTNERS IX, L.P.

    HEALTHCARE PARTNERS IX, LLC

    • 10% Owner
    No longer subject to file 2021-02-09 0

    HEALTHCARE VENTURES VIII, L.P.

    HEALTHCARE PARTNERS VIII, LLC

    HEALTHCARE PARTNERS VIII, L.P.

    • 10% Owner
    No longer subject to file 2020-12-28 0

    LITTLECHILD JOHN W

    • Director
    • 10% Owner
    0 2020-03-02 0

    LILLY ELI & CO

    • 10% Owner
    0 2018-07-30 0

    WERNER HAROLD R

    • 10% Owner
    0 2018-07-30 0

    HEALTHCARE VENTURES VIII, L.P.

    HEALTHCARE PARTNERS VIII, L.P.

    HEALTHCARE PARTNERS VIII, LLC

    WERNER HAROLD R

    • 10% Owner
    2,618,406 2017-01-20 0

    HEALTHCARE VENTURES IX, L.P.

    HEALTHCARE PARTNERS IX, LLC

    • 10% Owner
    2,515,607 2017-01-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    LEAP THERAPEUTICS INC LPTX 2023-01-27 22:15:03 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 21:45:04 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 21:15:04 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 20:45:03 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 20:15:04 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 19:45:03 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 19:15:03 UTC 2.4178 1.9022 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 18:45:04 UTC 2.347 1.973 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 18:15:03 UTC 2.347 1.973 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 17:45:03 UTC 2.347 1.973 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 17:15:04 UTC 2.347 1.973 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 16:45:03 UTC 2.3771 1.9429 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 16:15:03 UTC 2.3771 1.9429 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 15:45:03 UTC 2.3771 1.9429 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 15:15:04 UTC 2.3771 1.9429 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 14:45:04 UTC 2.3771 1.9429 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 14:15:03 UTC 2.3771 1.9429 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 13:45:03 UTC 2.1291 2.1909 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 13:15:03 UTC 2.1291 2.1909 3500000
    LEAP THERAPEUTICS INC LPTX 2023-01-27 12:45:03 UTC 2.1291 2.1909 3500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments